859
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Cervical Tourniquet During Cesarean Section to Reduce Bleeding in Morbidly Adherent Placenta: a Pilot Study

ORCID Icon, , , , , & show all
Article: FSO789 | Received 17 Jul 2021, Accepted 07 Feb 2022, Published online: 08 Mar 2022

References

  • ClarkS , BelfortM , DildyG , HerbstM , MeyersJ , HankinsG. Maternal death in the 21st century: causes, prevention, and relationship to caesarean delivery. Am. J. Obstet. Gynecol.199, 36.e1–5 (2008).
  • WHO. Maternal Mortality in 2000. Estimates Developed by WHO, UNICEF and UNFPA. WHO, Geneva, Switzerland (2004).
  • EggesbøT , GjessingLK. Haemorrhage after caesarean delivery. Tidsskr. Nor. Legeforen.120, 2864–2866 (2000) ( in Norwegian, English summary).
  • NaefRW , ChauhanSP , ChevalierSP , RobertsWE , MeydrechEF , MorrisonJC. Prediction of hemorrhage at caesarean delivery. Obstet. Gynecol.83, 923–926 (1994).
  • Al-ZirqiI , VangenS , ForsenL , Stray-PedersenB. Prevalence and risk factors of severe obstetric haemorrhage. BJOG115, 1265–1272 (2008).
  • Bouvier-ColleMH , PéquignotF , JouglasE. Mise au point sur la mortalité maternelle en France: fréquence, tendances et causes. J. Gynecol. Obstet. Biol. Reprod.30, 768–775 (2001).
  • CombsAA , MurphyEL , LarosRK. Factors associated with hemorrhage in cesarean deliveries. Obstet. Gynecol.77, 77–82 (1991).
  • BergholtT , StenderupJK , Vedsted-JakobsenA , HelmP , LenstrupC. Intraoperative surgical complications during caesarean section: an observational study of the incidence and risk factors. Acta Obstet. Gynecol. Scand.82, 251–256 (2003).
  • OyeleseY , SmulianJC. Placenta previa, placenta accreta, and vasa previa. Obstet. Gynecol.107, 927–941 (2006).
  • NormanJ. Haemorrhage. Centre for Maternal and Child Enquiries (CMACE). In: Saving mothers’lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG.118(Suppl. 1), 71–76 (2011).
  • OnwereC , Gurol-UrganciI , CromwellDA , MahmoodTA , TempletonA , vander Meulen JH. Maternal morbidity associated with placenta praevia among women who had elective caesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol.159, 62–66 (2011).
  • EsakoffTF , SparksTN , KaimalAJet al.Diagnosis and morbidity of placenta accreta. Ultrasound Obstet. Gynecol.37, 324–327 (2011).
  • HigginsMF , MonteithC , FoleyM , O’HerlihyC. Real increasing incidence of hysterectomy for placenta accreta following previous caesarean section. Eur. J. Obstet. Gynecol. Reprod. Biol.171, 54–56 (2013).
  • SilverRM , LandonMB , RouseDJet al.Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet. Gynecol.107, 1226–1232 (2006).
  • Committee opinion no. 529: placenta accreta. Committee opinion no. 529: placenta accreta.Committee on Obstetric Practice.Obstet. Gynecol.120(1), 207–211 (2012).
  • O'BrienD , BabikerE , O'SullivanOet al.Prediction of peripartum hysterectomy and end organ dysfunction in major obstetric haemorrhage. Eur. J. Obstet. Gynecol. Reprod. Biol.153, 165–169 (2010).
  • GarmiG , SalimR. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet. Gynecol. Int.2012, 873929 (2012).
  • UstaIM , HobeikaEM , MusaAA , GabrielGE , NassarAH. Placenta previa-accreta: risk factors and complications. Am. J. Obstet. Gynecol.193, 1045–1049 (2005).
  • Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet. Gynecol.120(1), 207–211 (2012).
  • MogosMF , SalemiJL , AshleyM , WhitemanVE , SalihuHM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998–2011. J. Matern. Fetal Neonatal Med.29, 1077–1082 (2016).
  • EshkoliT , WeintraubAY , SergienkoR , SheinerE. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am. J. Obstet. Gynecol.208, 219. e1–e7 (2013).
  • BowmanZS , EllerAG , BardsleyTR , GreeneT , VarnerMW , SilverRM. Risk factors for placenta accreta: a large prospective cohort. Am. J. Perinatol.31, 799–804 (2014).
  • BaldwinHJ , PattersonJA , NippitaTAet al.Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet. Gynecol.131, 227–233 (2018).
  • GarmiG , SalimR. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet. Gynecol. Int.2012, 873929 (2012).
  • SilverRM , LandonMB , RouseDJet al.Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet. Gynecol.107, 1226–1232 (2006).
  • KupfermincMJ , TamuraRK , WigtonTR , GlassenbergR , SocolML. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet. Gynecol.82, 266–269 (1993).
  • LyellDJ , FaucettAM , BaerRJet al.Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J. Perinatol.35, 570–574 (2015).
  • EllerAG , PorterTF , SoissonP , SilverRM. Optimal management strategies for placenta accreta. BJOG116, 648–654 (2009).
  • TanCH , TayKH , SheahKet al.Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta. AJR Am. J. Roentgenol.189, 1158–1163 (2007).
  • CourbièreB , BretelleF , PorcuG , GamerreM , BlancB. Conservative treatment of placenta accreta. J. Gynecol. Obstet. Biol. Reprod. (Paris)32, 549–554 (2003).
  • SentilhesL , AmbroselliC , KayemGet al.Maternal outcome after conservative treatment of placenta accreta. Obstet. Gynecol.115, 526–534 (2010).
  • ClausenC , LonnL , Langhoff-RoosJ. Management of placenta percreta: a review of published cases. Acta Obstet. Gynecol. Scand.93, 138–143 (2014).
  • FoxKA , ShamshirsazA , CarusiDet al.Conservative management of morbidly adherent placenta: expert review. Am. J. Obstet. Gynecol.213, 755–760 (2015).
  • DilauroMD , DasonS , AthreyaS. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: literature review and analysis. Clin. Radiol.67, 515–520 (2012).
  • D’SouzaDL , KingdomJC , AmsalemHet al.Conservative management of invasive placenta using combined prophylactic internal iliac artery balloon occlusion and immediate postoperative uterine artery embolization. Can. Assoc. Radiol. J.66, 179–184 (2015).
  • BishopS , ButlerK , MonaghanSet al.Multiple complications following the use of prophylactic internal iliac artery balloon catheterisation in a patient with placenta percreta. Int. J. Obstet. Anesth.20, 70–73 (2011).
  • ShehataA. Uterine sparing techniques in placenta accreta. Obstet. Gynecol. Int. J.5, 00143 (2016).
  • ShazlySA , BadeeAY , AliMK. The use of multiple 8 compression suturing as a novel procedure to preserve fertility in patients with placenta accreta: case series. Aust. N. Z. J. Obstet. Gynaecol.52, 395–399 (2012).
  • SalvatJ , SchmidtMH , GuilbertM , MartinoA. Vascular ligation for severe obstetrical hemorrhage: review of the literature. J. Gynecol. Obstet. Biol. Reprod. (Paris)31, 629–639 (2002).
  • GungorT , SimsekA , OzdemirAOet al.Surgical treatment of intractable postpartum hemorrhage and changing trends in modern obstetric perspective. Arch. Gynecol. Obstet.280, 351–355 (2009).
  • JoshiVM , OtivSR , MajumderR , NikamYA , ShrivastavaM. Internal iliac artery ligation for arresting postpartum hemorrhage. BJOG114, 356–361 (2007).
  • DoumouchtsisSK , PapageorghiouAT , ArulkumaranS. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet. Gynecol. Surv.62, 540–547 (2007).
  • DawlatlyB , WongI , KhanK , AgnihotriS. Using the cervix to stop bleeding in a woman with placenta accreta: a case report. BJOG114, 502–504 (2007).
  • ElGelany SAA , AbdelraheimAR , MohammedMMet al.The cervix as a natural tamponade in postpartum hemorrhage caused by placenta previa and placenta previa accreta: a prospective study. BMC Pregnancy Childbirth15, 295 (2015).
  • MadnyE , AtwaK , EidA , FaragM. Use of cervical inversion technique as a tamponade to control postpartum hemorrhage caused by placenta previa and placenta previa focal accreta. Evid. Based Women Health J.9, 344–348 (2019).
  • RubinIC. The pericervical broad ligament tourniquet for preventive hemostasis in myomectomy. Obstet. Gynecol.1, 668–671 (1953).
  • KotsujiF , NishijimaK , KurokawaTet al.Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. BJOG120, 1144–1149 (2013).
  • MengJL , GongWY , WangS , NiXJ , ZuoCT , GuYZ. Two-tourniquet sequential blocking as a simple intervention for hemorrhage during cesarean delivery for placenta previa accreta. Int. J. Gynaecol. Obstet.138, 361–362 (2017).
  • ShmakovRG , VinitskiyAA , ChuprininVD , YarotskayaEL , SukhikhGT. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery. J. Matern. Fetal Neonatal Med.32, 2042–2048 (2019).
  • Palacios-JaraquemadaJM , FiorilloA , HamerJ , MartinezM , BrunoC. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. J. Matern. Fetal Neonatal Med.26, 1–8 (2020).